Evaluation of switch-mediated costimulation in trans on universal CAR-T cells (UniCAR) targeting CD123-positive AML

Chimeric antigen receptor T cells (CAR-T) targeting CD19 have achieved significant success in patients with B cell malignancies. To date, implementation of CAR-T in other indications remains challenging due to the lack of truly tumor-specific antigens as well as control of CAR-T activity in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Jan-Erik, Loff, Simon, Dietrich, Josephine, Spehr, Johannes, Jurado Jiménez, Gabriel, von Bonin, Malte, Ehninger, Gerhard, Cartellieri, Marc, Ehninger, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274446/
https://www.ncbi.nlm.nih.gov/pubmed/34290907
http://dx.doi.org/10.1080/2162402X.2021.1945804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274446/
https://www.ncbi.nlm.nih.gov/pubmed/34290907
http://dx.doi.org/10.1080/2162402X.2021.1945804

Ejemplares similares